Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_assertion type Assertion NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_head.
- NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_assertion description "[If the response to RAF kinase inhibition is dependent on the presence of an activated BRAF protein, it will be necessary to evaluate cases of malignant melanoma for the presence or absence of BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_provenance.
- NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_assertion evidence source_evidence_literature NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_provenance.
- NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_assertion SIO_000772 15948115 NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_provenance.
- NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_assertion wasDerivedFrom befree-20150227 NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_provenance.
- NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_assertion wasGeneratedBy ECO_0000203 NP911221.RAy4x-KpLq1M83rOyScs8riq_gISqnKnGgjOCba3xlsLU130_provenance.